Enter the first few characters of Company and click 'Go'
Concord Drugs Ltd. Company Financial Ratios Analysis
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
|
PER SHARE RATIOS |
Adjusted EPS (Rs.) |
0.96 |
1.82 |
-0.55 |
0.38 |
0.52 |
Adjusted Cash EPS (Rs.) |
2.68 |
3.84 |
1.01 |
2.05 |
2.69 |
Reported EPS (Rs.) |
0.96 |
1.82 |
3.75 |
0.38 |
0.52 |
Reported Cash EPS (Rs.) |
2.68 |
3.84 |
5.31 |
2.05 |
2.69 |
Dividend Per Share |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Operating Profit Per Share (Rs.) |
4.66 |
6.40 |
3.68 |
3.82 |
4.65 |
Book Value (Excl Rev Res) Per Share (Rs.) |
34.03 |
32.44 |
30.61 |
26.86 |
29.45 |
Book Value (Incl Rev Res) Per Share (Rs.) |
34.03 |
32.44 |
30.61 |
26.86 |
29.45 |
Net Operating Income Per Share (Rs.) |
55.09 |
67.43 |
58.74 |
58.71 |
61.15 |
Free Reserves Per Share (Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
PROFITABILITY RATIOS |
Operating Margin (%) |
8.46 |
9.48 |
6.26 |
6.51 |
7.61 |
Adjusted Cash Margin (%) |
4.86 |
5.68 |
1.71 |
3.48 |
4.39 |
Adjusted Return On Net Worth (%) |
2.81 |
5.62 |
-1.79 |
1.39 |
1.75 |
Reported Return On Net Worth (%) |
2.81 |
5.62 |
12.26 |
1.39 |
1.75 |
Return On long Term Funds (%) |
8.40 |
12.73 |
7.12 |
8.21 |
8.52 |
|
LEVERAGE RATIOS |
Long Term Debt / Equity |
0.03 |
0.09 |
0.02 |
0.04 |
0.03 |
Owners fund as % of total Source |
68.17 |
63.31 |
67.35 |
71.05 |
70.20 |
Fixed Assets Turnover Ratio |
1.12 |
1.39 |
1.41 |
1.55 |
1.49 |
|
LIQUIDITY RATIOS |
Current Ratio |
4.09 |
3.60 |
3.55 |
1.86 |
1.42 |
Current Ratio (Inc. ST Loans) |
1.10 |
1.06 |
1.03 |
1.10 |
1.04 |
Quick Ratio |
2.36 |
3.60 |
2.38 |
1.20 |
1.04 |
Fixed Assets Turnover Ratio |
1.12 |
1.39 |
1.41 |
1.55 |
1.49 |
|
PAYOUT RATIOS |
Dividend payout Ratio (Net Profit) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Dividend payout Ratio (Cash Profit) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Earning Retention Ratio |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
Cash Earnings Retention Ratio |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
|
COVERAGE RATIOS |
Adjusted Cash Flow Time Total Debt |
5.93 |
4.89 |
14.68 |
5.34 |
4.64 |
Financial Charges Coverage Ratio |
2.68 |
3.39 |
2.33 |
2.24 |
2.35 |
Fin. Charges Cov.Ratio (Post Tax) |
2.54 |
3.00 |
4.27 |
2.16 |
2.33 |
|
COMPONENT RATIOS |
Material Cost Component(% earnings) |
78.69 |
79.35 |
79.04 |
82.16 |
81.44 |
Selling Cost Component |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Exports as percent of Total Sales |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Import Comp. in Raw Mat. Consumed |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Long term assets / Total Assets |
0.27 |
0.26 |
0.28 |
0.20 |
0.15 |
Bonus Component In Equity Capital (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |